Background: The corona virus disease (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS CoV-2) virus has affected the whole world. Researches are …

Background The role of the antiviral therapy in treatment of COVID-19 is still a matter to be
investigated. Also efficacy and safety of antiviral regimens were not compared according …

Background: COVID-19 is a new disease for which a definitive treatment has not yet been
proposed. Objectives: The present study aimed to investigate the effect of combination …

Background: Multiple case reports have shown promising results with remdesivir,
tocilizumab and convalescent plasma. We evaluated the efficacy and safety of combination …

Background There is no identified pharmacological therapy for COVID-19 patients, where
potential therapeutic strategies are underway to determine effective therapy under such …

Background. Use of Hydroxychloroquine with or without Azithromycin is repurposed in
SARS-CoV-2 in the absence of definitive treatment. Objective. To evaluate the association …

Background: The purpose of this study is to find out the adverse effect of several medications
that are administered for the treatment of patients who have mild, moderate and severe …

Background: The ongoing pandemic has highlighted the need for an effective treatment of
COVID-19 patients and prevention of SARS-CoV-2 community transmission. Methods: We …

Objective: Since the severity of symptoms affects the treatment option for Coronavirus
Disease 2019 (COVID-19) patients, the treatment pattern for mild to moderate non-ICU …

The novel Corona virus disease 2019 is a new pandemic experienced worldwide recently in
the year 2020 affecting millions regardless of age, gender, race and religion. This …